You have lived with type 2 diabetes for more than a decade. You pay around $600 a month for health insurance. The refills arrive on time and the visits happen when the plan allows them. In all that time, no clinician has laid out the whole metabolic picture for you. Nobody has shown you what your blood sugar, your insulin and your heart markers are doing together or why the numbers have stayed where they are.
You have now found a membership that asks $598 for its first two months. The question you typed was a fair one. With type 2 diabetes not well controlled and a premium this high already, is that money worth it?
The $598 is a hold on your card at sign-up. It is charged only once a clinician accepts you into care. If the clinician cannot accept you, the hold is released and you are never charged. Once you are accepted, the first two months are charged and are non-refundable. After that, the membership is $299 a month, month to month.
GoodLife Health is a clinician-led membership that follows type 2 diabetes online with an A1C every quarter. Where a clinician judges it indicated, it prescribes branded medication, including Mounjaro. It pairs with your insurance for catastrophic cover and replaces the primary-care relationship. What follows sets out what that buys, what it leaves to your plan and who should keep their money.
- The $598 is a hold, charged and non-refundable once a clinician accepts you, released uncharged if one cannot.
- After the first two months, the membership is $299 a month, month to month.
- The fee buys four cardiometabolic panels a year, a clinician who stays and every result in your hands.
- Medication goes to your pharmacy at its own price and GoodLife Health takes nothing on it.
- The membership pairs with your insurance for catastrophic cover and does not replace it.
- It promises no A1C result and is wrong for anyone whose diabetes is already explained and well managed.
More than a decade of refills and still no explanation
Most people who have lived with diabetes this long know the rhythm of the visit. An A1C is drawn and read. If it has crept up, a dose goes up or another medication is added. You are told to watch the carbohydrates and to move more. The visit ends and the next one is months away.
Insurance-based primary care runs between eight and 18 minutes a visit, the range our guide to the real ROI of a $299 membership uses for that model. That is enough time to read one number and write one prescription. It is too little time to put several years of results side by side, ask what your insulin is doing or explain how your cholesterol markers relate to your blood sugar. None of this is a failure of the person in the room. The visit was built to renew a plan. It does that well.
You may have heard the same sentence for years: “Your numbers are about the same.” Early on, it sounded like stability. After a decade, it sounds like nobody is looking closely. Some people have also been told, kindly or otherwise, that the real problem is their discipline. If that has been your experience, set it aside for the length of this page. A decade of managing a chronic condition is a decade of daily work that a short visit rarely sees.
Meanwhile, the money keeps moving. You pay around $600 a month for coverage. Many plans also carry a deductible that has to be met before most care is paid for. The 2025 KFF Employer Health Benefits Survey put the average deductible for a worker at $1,886.
That premium does real work. It protects you from a hospital bill you could not absorb. It pays for the specialist, the imaging and the admission if you ever need them. What it has not bought, in more than a decade, is one clinician who knows your results and explains them to you.
Your insurance covers the hospital you may one day need but has paid no one to explain your numbers.
The hesitation you feel is reasonable. You already spend a great deal on health care and you are being asked to spend more. This page will not tell you the extra money is small. It is real money. The useful question is what it buys that your premium has not.
What a single number cannot show you
An A1C is the number most diabetes visits are built around. Read alone and read once, it can say whether things look better or worse than last time. It cannot say why.
The why sits in the markers beside it. A cardiometabolic panel reads glucose control, insulin and the heart markers as one picture. In the GoodLife Health panel, that means an A1C and fasting insulin read side by side, with ApoB, Lp(a) and hs-CRP in every panel and a TSH With Reflex To Free T4 every quarter. Each answers a different question. Together, they let a clinician see more than whether one number went up.
Look back through your own results and count how often fasting insulin, ApoB or Lp(a) appear. If the answer is never, nobody has been reading the picture this page describes. That is a fact about how your care was organized. It says nothing about how hard you have tried.
The second missing piece is time. One panel shows where you stand. Four panels a year, drawn every 90 days and read by the same clinician, show which way you are moving. A decade of single readings, each looked at once and filed, does not build that line. When the same person reads the March panel against the December one, a small change has a context. When a different person reads each one in a short visit, it has none.
The third missing piece is the order of things. When the numbers stall, the reflex in a short visit is to add something. A labs-first model works the other way. It tests first and treats second, so the clinician looks for the reason before writing the next prescription. Sometimes, the answer is a medication. Sometimes, it is a change to the one you already take. Sometimes, it is a marker that had never been drawn.
Medicine is moving toward testing before treating and toward prices a patient can see. In September 2026, the manufacturers of Wegovy and Zepbound each published their own self-pay prices through NovoCare and LillyDirect. A membership that reads ApoB and fasting insulin where a short visit reads LDL and glucose belongs to the same shift.
We cannot tell you from here why your numbers have stalled. That answer comes from your results, read together by a clinician who has all of them. We also cannot promise that reading them will lower your A1C. Nobody honest can. A decade of care built around one number has not produced an explanation for you. A panel read whole, quarter after quarter, is where one comes from.
A1C and fasting insulin are read together with ApoB, Lp(a) and hs-CRP, so a change in one marker is read against the others and against your earlier panels.
What $299 a month buys and what stays with your insurance
Start with the price. The membership is $299 a month. At sign-up, $598 is held on your card to cover the first two months. It is charged only once a clinician accepts you. If the clinician cannot accept you, the hold is released and you are never charged. Once you are accepted, those two months are charged and are non-refundable. From month three, the membership is month to month. A full year is $3,588.
The fee covers clinicians licensed in all fifty states, four cardiometabolic lab panels a year, every result in your hands, video visits and asynchronous messaging with the care team between visits. It is the same whatever medication is indicated and whatever the dose. There is no molecule upcharge and no dose upcharge.
Medication is unbundled. When a clinician judges it indicated, it is prescribed to the pharmacy you choose at that pharmacy's own price. GoodLife Health sets nothing, sees nothing and takes nothing on it. Everything prescribed is branded and FDA-approved. The formulary includes Mounjaro and Ozempic as well as Wegovy and Zepbound, each prescribed only where a clinician judges it indicated.
Whether your plan covers a medication is between you, your plan and your pharmacy. We do not promise coverage. Prior authorization is the pharmacy's process. GoodLife Health does not run it, speed it or win it. If a clinician prescribes a GLP-1 and your plan declines it, the manufacturers publish their own self-pay prices. In September 2026, LillyDirect listed Zepbound vials at $299 to $449 a month depending on dose. Through NovoCare, Wegovy pens were $199 a month for the first two fills (an introductory offer for new patients through December 2026) and $349 a month after. Those are the manufacturers' figures. The membership fee does not move with them.
That is the integrity of the model. There are cheaper places to get a prescription online. Some advertise a low monthly fee and earn their margin on the medication. GoodLife Health takes nothing on what it prescribes. A clinician here gains nothing from a higher dose or a second drug, so the only reason to prescribe either is what your panel shows.
The limits are as important as the fee. The membership does not replace your insurance. Keep the insurance for the hospital. The membership is the clinician. Your plan pays for specialists, imaging and hospital care, which the membership does not cover. GoodLife Health is precision direct primary care for cardiometabolic optimization, so it does not handle everything a general practice handles. It does not run a continuous glucose monitor program or prescribe compounded GLP-1. It makes no promise about your A1C, your weight or remission.
If you are comparing practices, the direct primary care cost guide lists four questions to ask before joining any of them. The first is whether labs are included.
Your insurance and the membership
What each one pays for
| Question | Your insurance | GoodLife Health membership |
|---|---|---|
| Monthly cost | Around $600 (your premium) | $299, month to month after the first two months |
| What it is for | Specialists, imaging, hospital care and catastrophic cover | The primary-care relationship for cardiometabolic care |
| Labs | Whatever your plan covers | Four cardiometabolic panels a year, every result in your hands |
| Time with a clinician | Eight to 18 minutes a visit in insurance-based primary care | Video visits and messaging with the care team between visits |
| Medication | Coverage decided by your plan and your pharmacy | Prescribed to your pharmacy at its price, nothing taken on it |
How to decide this week
You can do most of the useful work before you spend anything. Pull every lab result from the past few years, either from your patient portal or by asking the office. Write down each A1C with its date. List every medication you take and its dose. Next, look for three markers: fasting insulin, ApoB and Lp(a). If they are missing, ask your current clinician whether they can be drawn. That conversation is worth having whether or not you join.
If you hope to pay from an HSA or FSA, settle that first. We don't promise the membership fee is HSA or FSA eligible. Your account administrator decides, so check with them before using those funds.
Finally, weigh one question. Over the next two months, would a clinician who reads that whole panel with you, answers your messages between visits and stays with you afterward be worth the money to your household? If the answer is yes, the eligibility check is the next step. If the answer is no, the list you made is still yours. Take it to your next visit and ask for the markers that are missing.
The path has a stop built into it. You complete the eligibility check, then the intake, then checkout. A clinician reviews you after that. Not everyone is accepted. If you are not, the hold is released and you are never charged. Once you are accepted, the first two months are charged and are non-refundable.
Who this is not for
Some readers should keep their money. We would rather say so here than after checkout.
If your diabetes is well controlled and a clinician already reads the whole panel with you, stay with that clinician. The membership would add a bill without adding an explanation.
If you want a prescription at the lowest monthly fee with no labs, this is the wrong place. A $99 app will suit that goal better. We test before we treat. The testing is part of the price and is the reason the price exists.
If you are looking for a continuous glucose monitor program, compounded medication or a promise of remission, we offer none of them. If you hope the membership will let you drop your insurance, it will not. It is built to sit beside a plan. If the first two months would strain your household budget, wait until they would not. A long-standing condition is better served by care you can keep than by two months you regret.
The membership is for residents of the fifty states. It is not available to readers outside the United States.
The offer is simple to state. GoodLife Health is $299 a month. At sign-up, $598 is held on your card for the first two months and is charged only once a clinician accepts you. If the clinician cannot accept you, the hold is released and you are never charged. Once you are accepted, those two months are charged and are non-refundable. After that, the membership is month to month. The fee buys four cardiometabolic panels a year, a clinician who stays and medication prescribed to your pharmacy at that pharmacy's price with nothing taken on it. In return, you get the explanation a decade of short visits never produced, your markers followed every quarter and no more eight-minute visits. The model is different because it tests first and treats second. It sells neither the drug nor the dose. The reason to start now is your own record. You have had diabetes for more than a decade and your numbers have stayed where they are. You already pay around $600 a month for coverage. Another quarter of single readings is unlikely to explain what a decade of them has not.
Related Reading
- The Real ROI of a $299/Month Health Membership: Every Alternative, Priced Honestly
- Direct Primary Care Membership Cost: 2026 Guide
References
- 2025 Employer Health Benefits Survey — Kaiser Family Foundation. 2025. www.kff.org/health-costs/2025-employer-health-benefits-survey/
- Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings
- NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html